Assessment of the therapeutic range of tiapride in patients with tardive dyskinesia.
- 1 September 1986
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 49 (9) , 1055-1058
- https://doi.org/10.1136/jnnp.49.9.1055
Abstract
Ten patients with tardive dyskinesia were treated with tiapride at an increasing dosage to establish the dose-concentration relationship and the dose-effect relationship. The effect was scored with the Abnormal Involuntary Movement Scale (AIMS) and the Doppler-radar method. The intra individual dosage-serum concentration correlation coefficients varied from 0.86 to 0.99 and the slopes of the individual regression lines varied from 0.16 to 0.58. All patients showed a diminution of their involuntary movements during the treatment period. A negative correlation coefficient was found between the dosage of tiapride and the AIMS; range -0.22 till -0.93, mean: -0.65 .+-. 0.23 (SD). The Doppler-radar method results were inconclusive. No side-effects were observed.This publication has 8 references indexed in Scilit:
- Effects of tiapride in tardive dyskinesiaPsychopharmacology, 1985
- [Use of tiapride in persistent tardive dyskinesia following treatment with neuroleptics].1983
- Quantification of choreatic movements by Doppler radarActa Neurologica Scandinavica, 1982
- [Clinical trial of tiapride in patients with dyskinesia (author's transl)].1982
- PHARMACOKINETICS OF TIAPRIDE AND ABSOLUTE BIOAVAILABILITY OF 3 EXTRA-VASCULAR FORMS1982
- Tiapride in the treatment of tardive dyskinesiaActa Neurologica Scandinavica, 1982
- Tiapride in the treatment of Huntington's choreaActa Neurologica Scandinavica, 1981
- [Tiapride in the treatment of neurological and psychiatric disorders in the elderly (author's transl)].1981